Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Investors have taken to punishing pharma companies that appear unable to gauge demand for their top products. Consider Pfizer. The company’s inability to accurately project demand for its Covid-19 ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.
This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Can you pitch in a few bucks to help fund Mother Jones' investigative journalism? We're a nonprofit (so it's tax-deductible), ...
Elsewhere, Merck’s 21-serotype pneumococcal disease ... while the latest U.S. COVID vaccine administration figures remain “largely aligned” with last year's numbers, according to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results